| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Vitamin B3 | Dyslipidemia | 6 | PM | 33761625 | 📋 | The efficacy of niacin supplementation in type 2 diabetes patients: Study protocol of a randomized controlled trial |
| Vitamin B3 | Dyslipidemia | 1 | PM | 29753732 | 📋 | Niacin Action in the Atherogenic Mixed Dyslipidemia of Metabolic Syndrome: Insights From Metabolic Biomarker Profiling and Network Analysis |
| Vitamin B3 | Dyslipidemia | 5 | PM | 26598845 | 📋 | Niacin and Chronic Kidney Disease |
| Vitamin B3 | Dyslipidemia | 4 | PM | 19545870 | 📋 | Management of Non-High-Density Lipoprotein Abnormalities |
| Vitamin B3 | Dyslipidemia | 2 | PM | 19240310 | 📋 | Efficacy and Safety of Combination of Extended Release Niacin and Atorvastatin in Patients With Low Levels of High Density Lipoprotein Cholesterol |
| Vitamin B3 | Dyslipidemia | 3 | PM | 17935553 | 📋 | The Effects of Extended-Release Niacin on Carotid Intimal Media Thickness, Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome |
| Vitamin B3 | HDL Low | 3 | PM | 32825822 | 📋 | Effect of niacin monotherapy on high density lipoprotein composition and function |
| Vitamin B3 | HDL Low | 1 | PM | 19240310 | 📋 | Efficacy and Safety of Combination of Extended Release Niacin and Atorvastatin in Patients With Low Levels of High Density Lipoprotein Cholesterol |
| Vitamin B3 | HDL Low | 2 | PM | 18316796 | 📋 | Niacin Inhibits Surface Expression of ATP Synthase Beta Chain in HepG2 Cells: Implications for Raising HDL |
| Vitamin B3 | HDL Low | 4 | PM | 17076985 | 📋 | The Effect of 24 Months of Combination Statin and Extended-Release Niacin on Carotid Intima-Media Thickness: ARBITER 3 |
| Vitamin B3 | Hypercholesterolemia | 1 | PM | 18402819 | 📋 | Effect of Niacin on Adipocyte Leptin in Hypercholesterolemic Rabbits |
| Vitamin B3 | Hyperglycemia | 1 | PM | 30021358 | 📋 | Therapeutic Effect of Vitamin B 3 on Hyperglycemia, Oxidative Stress and DNA Damage in Alloxan Induced Diabetic Rat Model |
| Vitamin B3 | Hyperlipidemia | 1 | PM | 27613388 | 📋 | Synergistic combinatorial antihyperlipidemic study of selected natural antioxidants; modulatory effects on lipid profile and endogenous antioxidants |
| Vitamin B3 | Hyperphosphatemia | 1 | PM | 26598845 | 📋 | Niacin and Chronic Kidney Disease |
| Vitamin B3 | Lipoprotein(a) High | 4 | PM | 29753732 | 📋 | Niacin Action in the Atherogenic Mixed Dyslipidemia of Metabolic Syndrome: Insights From Metabolic Biomarker Profiling and Network Analysis |
| Vitamin B3 | Lipoprotein(a) High | 2 | PM | 26710351 | 📋 | Lipoprotein apheresis for the treatment of elevated circulating levels of lipoprotein(a): a critical literature review |
| Vitamin B3 | Lipoprotein(a) High | 3 | PM | 20842562 | 📋 | Do We Know When and How to Lower Lipoprotein(a)? |
| Vitamin B3 | Lipoprotein(a) High | 1 | PM | 20153365 | 📋 | Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk |
